UNSPSC 51284011: Metacycline or methacycline

This classification denotes a macrolide antibiotic with the molecular formula C22H22N2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IR235I7C5P, chemically known as 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide but generally known as metacycline, which bears US NIH Compound Identifier 5281054. European Medicines Agency schedules Metacycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08801MIG.

UNSPSC 51284011 Metacycline or methacycline is a Commodity code showing a mismatch between its nominal scope and recent state and local procurement activity. The code specifies a single pharmaceutical compound, but the opportunities tagged under it reflect a much broader procurement pattern: state and local health agencies are buying naloxone kits, medical and first aid supplies for emergency response, and participating in cooperative purchasing agreements for generic multi-source pharmaceuticals and over-the-counter products distributed through authorized wholesalers. The actual work being solicited is the supply and delivery of medical consumables, emergency-response equipment, and pharmaceutical products to county health departments, municipal fire departments, and state health agencies participating in multistate cooperative purchasing vehicles.

Recent activity spans three states and multiple issuing-body types. The Minnesota Department of Administration's Office of State Procurement administered an MMCAP RFP (solicitation S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products for distribution across participating state and local facilities including Oregon; the City of Tampa issued an IFB (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, with a Small Local Business Enterprise set-aside and 5 percent bid discount; and Seminole County, Florida posted an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building. The Texas Health and Human Services Commission issued an RFI (HHS0017013) on April 3, 2026 to gather market intelligence on direct-to-manufacturer prescription programs. Issuing bodies include state health and human services agencies, county public health departments, municipal fire departments, and cooperative purchasing organizations serving multiple jurisdictions. The code shows limited recent activity directly aligned with its pharmaceutical-compound specification.